Here are five key notes:
1. Jennison Associates acquired 4,854 shares, now owning more than 1.07 million shares.
2. Jennison Associates now owns around 0.26 percent of HCA’s shares, worth around $83 million.
3. HCA traded down mid-day last week. The company has a 50-day moving average price of $67.73, with a 52-week low of $43.91.
4. HCA’s third quarter revenue was $9.86 billion, slightly down from the $9.9 billion consensus rating. The revenue was up 6.9 percent over the same period last year.
5. Recently Mizuho upped HCA’s price target from $86 to $103 and gave the stock a “buy” rating. Earlier in the year, JPMorgan Chase gave the company a “neutral” rating and $98 price objective.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.